Drugs / tetravalent inactivated enterovirus vaccine
tetravalent inactivated enterovirus vaccine
also known as
tetravalent inactivated enterovirus vaccine (Vero cell)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06754384 | Jan → Dec 2025 | hand, foot and mouth disease, herpangina | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tetravalent inactivated enterovirus vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06754384 ↗ |
| Known as | tetravalent inactivated enterovirus vaccine (Vero cell) | “Low-dose of tetravalent inactivated enterovirus vaccine (Vero cell)” NCT06754384 ↗ |
| Modality | Vaccine | “tetravalent inactivated enterovirus vaccine” NCT06754384 ↗ |